Neeraj Sharma

Array ( [id] => 5204563 [patent_doc_number] => 20070026044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Use of VEGF For Treating Bone Defects' [patent_app_type] => utility [patent_app_number] => 11/536569 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15106 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026044.pdf [firstpage_image] =>[orig_patent_app_number] => 11536569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731450 [patent_doc_number] => 20120014915 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-01-19 [patent_title] => 'Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders' [patent_app_type] => utility [patent_app_number] => 11/992558 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20641 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0014/20120014915.pdf [firstpage_image] =>[orig_patent_app_number] => 11992558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731450 [patent_doc_number] => 20120014915 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-01-19 [patent_title] => 'Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders' [patent_app_type] => utility [patent_app_number] => 11/992558 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20641 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0014/20120014915.pdf [firstpage_image] =>[orig_patent_app_number] => 11992558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995101 [patent_doc_number] => 20070010446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'METHODS FOR TREATING INFLAMMATION USING THYROID STIMULATING HORMONE' [patent_app_type] => utility [patent_app_number] => 11/468014 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16682 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010446.pdf [firstpage_image] =>[orig_patent_app_number] => 11468014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552737 [patent_doc_number] => 20090286723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Hybrid Polypeptides with Selectable Properties' [patent_app_type] => utility [patent_app_number] => 12/063420 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 65855 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286723.pdf [firstpage_image] =>[orig_patent_app_number] => 12063420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904494 [patent_doc_number] => 20080113908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/461604 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16520 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113908.pdf [firstpage_image] =>[orig_patent_app_number] => 11461604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5075282 [patent_doc_number] => 20070015257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Alpha-MSH related compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/490686 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19101 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015257.pdf [firstpage_image] =>[orig_patent_app_number] => 11490686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652116 [patent_doc_number] => 20080039372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation' [patent_app_type] => utility [patent_app_number] => 11/490005 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19996 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039372.pdf [firstpage_image] =>[orig_patent_app_number] => 11490005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5663316 [patent_doc_number] => 20060253912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro' [patent_app_type] => utility [patent_app_number] => 11/487228 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10756 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20060253912.pdf [firstpage_image] =>[orig_patent_app_number] => 11487228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627713 [patent_doc_number] => 20100004168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Use of Crystallin For The Modulation of Angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/309026 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28510 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004168.pdf [firstpage_image] =>[orig_patent_app_number] => 12309026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205588 [patent_doc_number] => 20070027070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Medicinal Uses of Mu-Opioid Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/427606 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10280 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027070.pdf [firstpage_image] =>[orig_patent_app_number] => 11427606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228845 [patent_doc_number] => 20100183583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'GALK1S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/993191 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17799 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183583.pdf [firstpage_image] =>[orig_patent_app_number] => 11993191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642680 [patent_doc_number] => 20060281135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Methods for diagnosing and treating cerebrovascular events based on NR2 peptides' [patent_app_type] => utility [patent_app_number] => 11/451679 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11060 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281135.pdf [firstpage_image] =>[orig_patent_app_number] => 11451679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515364 [patent_doc_number] => 20090215671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Compositions And Methods For Treatment of Neural Disorders Using Transforming Growth Factor-Beta Superfamily Proteins And Their Antagonists' [patent_app_type] => utility [patent_app_number] => 11/915665 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215671.pdf [firstpage_image] =>[orig_patent_app_number] => 11915665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928886 [patent_doc_number] => 20110038845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Diagnosis and treatment for endometriosis' [patent_app_type] => utility [patent_app_number] => 11/919920 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25496 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038845.pdf [firstpage_image] =>[orig_patent_app_number] => 11919920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392140 [patent_doc_number] => 20090209453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Glycoprotein Hormone Analogs' [patent_app_type] => utility [patent_app_number] => 11/911571 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 26575 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209453.pdf [firstpage_image] =>[orig_patent_app_number] => 11911571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034704 [patent_doc_number] => 20070099243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'METHOD FOR SEARCHING MYELIN USING GONADOTROPIN-RELEASING HORMONE RECEPTORS AS A NEW BIOMARKER' [patent_app_type] => utility [patent_app_number] => 11/277836 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4443 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099243.pdf [firstpage_image] =>[orig_patent_app_number] => 11277836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5491040 [patent_doc_number] => 20090292111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'ROR-alpha Promoting the Induction of Bmall' [patent_app_type] => utility [patent_app_number] => 11/909058 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7742 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20090292111.pdf [firstpage_image] =>[orig_patent_app_number] => 11909058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204506 [patent_doc_number] => 20070025986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Modulation of HCN channels by second messengers' [patent_app_type] => utility [patent_app_number] => 11/375979 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17788 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025986.pdf [firstpage_image] =>[orig_patent_app_number] => 11375979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812807 [patent_doc_number] => 20080193438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Eef2k as Modifiers of the Pten/Akt Pathway and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/908114 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18238 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193438.pdf [firstpage_image] =>[orig_patent_app_number] => 11908114 [rel_patent_id] =>[rel_patent_doc_number] =>)